Sandström M - Search Results

1

The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy.

Lannergård A, Viberg A, Cars O, Karlsson MO, Sandström M, Larsson A. Lannergård A, et al. Among authors: sandstrom m. Scand J Infect Dis. 2009;41(9):663-71. doi: 10.1080/00365540903127417. Scand J Infect Dis. 2009. PMID: 19626562

2

Determination of cefuroxime in human serum or plasma by liquid chromatography with electrospray tandem mass spectrometry.

Viberg A, Sandström M, Jansson B. Viberg A, et al. Among authors: sandstrom m. Rapid Commun Mass Spectrom. 2004;18(6):707-10. doi: 10.1002/rcm.1396. Rapid Commun Mass Spectrom. 2004. PMID: 15052582

3

A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Viberg A, Lannergård A, Larsson A, Cars O, Karlsson MO, Sandström M. Viberg A, et al. Among authors: sandstrom m. Br J Clin Pharmacol. 2006 Sep;62(3):297-303. doi: 10.1111/j.1365-2125.2006.02652.x. Br J Clin Pharmacol. 2006. PMID: 16934045 Free PMC article.

4

Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.

Nielsen EI, Viberg A, Löwdin E, Cars O, Karlsson MO, Sandström M. Nielsen EI, et al. Among authors: sandstrom m. Antimicrob Agents Chemother. 2007 Jan;51(1):128-36. doi: 10.1128/AAC.00604-06. Epub 2006 Oct 23. Antimicrob Agents Chemother. 2007. PMID: 17060524 Free PMC article.

5

Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model.

Friberg LE, Sandström M, Karlsson MO. Friberg LE, et al. Among authors: sandstrom m. Invest New Drugs. 2010 Dec;28(6):744-53. doi: 10.1007/s10637-009-9308-7. Epub 2009 Aug 27. Invest New Drugs. 2010. PMID: 19711011

6

Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression.

Hansson EK, Wallin JE, Lindman H, Sandström M, Karlsson MO, Friberg LE. Hansson EK, et al. Among authors: sandstrom m. Cancer Chemother Pharmacol. 2010 Apr;65(5):839-48. doi: 10.1007/s00280-009-1089-3. Epub 2009 Aug 14. Cancer Chemother Pharmacol. 2010. PMID: 19680655

7

Pharmacokinetic/pharmacodynamic modelling in oncological drug development.

Karlsson MO, Anehall T, Friberg LE, Henningsson A, Kloft C, Sandström M, Xie R. Karlsson MO, et al. Among authors: sandstrom m. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):206-11. doi: 10.1111/j.1742-7843.2005.pto960310.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733216 Free article. Review.

8

Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo.

Hassan S, Dhar S, Sandström M, Arsenau D, Budnikova M, Lokot I, Lobanov N, Karlsson MO, Larsson R, Lindhagen E. Hassan S, et al. Among authors: sandstrom m. Cancer Chemother Pharmacol. 2005 Jan;55(1):47-54. doi: 10.1007/s00280-004-0855-5. Epub 2004 Jul 20. Cancer Chemother Pharmacol. 2005. PMID: 15565443

9

Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.

Nielsen EI, Sandström M, Honoré PH, Ewald U, Friberg LE. Nielsen EI, et al. Among authors: sandstrom m. Clin Pharmacokinet. 2009;48(4):253-63. doi: 10.2165/00003088-200948040-00003. Clin Pharmacokinet. 2009. PMID: 19492870 Clinical Trial.

10

Assessment of the validity of a population pharmacokinetic model for epirubicin.

Ralph LD, Sandstrom M, Twelves C, Dobbs NA, Thomson AH. Ralph LD, et al. Among authors: sandstrom m. Br J Clin Pharmacol. 2006 Jul;62(1):47-55. doi: 10.1111/j.1365-2125.2006.02584.x. Br J Clin Pharmacol. 2006. PMID: 16842378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page